Elevated carcinoembryonic antigen tumour marker caused by head and neck cancer: A case report and literature study

2015 ◽  
Vol 19 (2) ◽  
pp. 106-110
Author(s):  
S.I. Vingerhoedt ◽  
E. Hauben ◽  
R. Hermans ◽  
V.L. Vander Poorten ◽  
S. Nuyts
Keyword(s):  
Head And Neck Cancer ◽  
Case Report ◽  
Carcinoembryonic Antigen ◽  
Head And Neck ◽  
Neck Cancer ◽  
Tumour Marker ◽  
Literature Study

Carcinoembryonic antigen and head and neck cancer

1991 ◽  
Vol 16 (2) ◽  
pp. 182-186 ◽  
Author(s):  
D.A.W. LAARMAN ◽  
G.J. VAN KAMP ◽  
A.J.M. BALM ◽  
B.J.M. BRAAKHUIS ◽  
G.B. SNOW
Keyword(s):  
Head And Neck Cancer ◽  
Carcinoembryonic Antigen ◽  
Head And Neck ◽  
Neck Cancer

Squamous Cell Carcinoma Antigen (SCC), Carcinoembryonic Antigen (CEA), and Tumour-Associated Trypsin Inhibitor (TATI) for Monitoring Head and Neck Cancer

1993 ◽  
Vol 8 (2) ◽  
pp. 81-87 ◽  
Author(s):  
D. Pectasides ◽  
J. Bourazanis ◽  
N. Economides ◽  
P. Pozadzidou ◽  
L. Gogou ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Recurrent Disease ◽  
Stage Iv ◽  
Serum Levels ◽  
Tumour Marker ◽  
Individual Therapy ◽  
Early Stages ◽  
Low Sensitivity

Eighty-eight patients with head and neck cancer were prospectively monitored, before and after treatment, by means of simultaneous serum SCC, CEA and TATI measurements. Thirty-two (36.6%) patients had early stages (I, II, III) and 56 (63.4%) advanced (stage IV) or recurrent disease. Pre-treatment serum SCC levels were elevated in 20.4% of patients, CEA in 27.2% and TATI in 4.5%. There was no correlation between the incidence of TATI elevation and tumour burden; this marker did not increase with progressing disease stages. CEA and SCC had low sensitivity in the early stages of head and neck cancer and reached 35.7% (20/56 patients) and 25% (14/56 patients) in stage IV or recurrent disease. Despite the low sensitivity of these tumour markers, there was a correlation between tumour marker levels and the course of the disease. This study indicates that the routine assessment of SCC, CEA and TATI serum levels is of no value. However, it can be used as a potential tool for monitoring the efficacy of individual therapy in both early and advanced stages of head and neck cancer.

Resection and replacement of the carotid artery in metastatic head and neck cancer: literature review and case report

2003 ◽  
Vol 32 (6) ◽  
pp. 645-650 ◽  
Author(s):  
Zs. Németh ◽  
Gy. Dömötör ◽  
M. Tálos ◽  
J. Barabás ◽  
M. Ujpál ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Case Report ◽  
Carotid Artery ◽  
Literature Review ◽  
Head And Neck ◽  
Neck Cancer
Sign in / Sign up

Export Citation Format

Share Document